COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00208078
Recruitment Status : Terminated (Not enough patient recruited)
First Posted : September 21, 2005
Last Update Posted : February 13, 2013
Information provided by (Responsible Party):
Dr Pierre-Régis Burgel, Cochin Hospital

Brief Summary:
There is no randomised controlled trials to determine the clinical effects of long term Non-Invasive Ventilation in Cystic Fibrosis patients.

Condition or disease Intervention/treatment Phase
Cystic Fibrosis Chronic Respiratory Failure Device: pressure support ventilator Phase 4

Detailed Description:

The effects of long term mechanical ventilation for the treatment of respiratory failure in patients with neuromuscular diseases is well established.

Long term non-invasive ventilation is commonly used in the treatment of Cystic Fibrosis patients with respiratory failure. However, the benefits of this treatment have never been studied in randomized control trials and are unknown.

The goal of this multicenter study is to evaluate the effects of the addition of non-invasive ventilation to the standard therapy in stable Cystic Fibrosis patients with chronic hypercapnia.

Two groups of patients will be followed: The first group will receive standard treatment for advanced Cystic Fibrosis according to international guidelines, the second group will receive the same treatment plus non-invasive ventilation (4H/day). The follow up time will be one year for each patient.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 36 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of the Effects of Long Term Non-Invasive Ventilation in Patient With Cystic Fibrosis and Chronic Hypercapnic Respiratory Failure.
Study Start Date : May 2005
Actual Primary Completion Date : May 2010
Actual Study Completion Date : May 2011

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
No Intervention: Usual medical therapy
Usual CF care
Experimental: Non-invasive ventilation
Pressure support ventilator (SAIME,AIROX)
Device: pressure support ventilator
Non invasive ventilation 4h/d 5 days a week

Primary Outcome Measures :
  1. The effect of non-invasive ventilation on room air PaCO2 at one year: Hypothesis is PaCO2 stabilisation in the non-invasive ventilation group compared to a increase in PaCO2 in the control group (standard treatment) [ Time Frame: ended 2011 ]

Secondary Outcome Measures :
  1. Effects of non-invasive ventilation on dyspnea index, functional status (6 minutes walking test, spirometric values), pulmonary exacerbations and body mass index (BMI) compared to standard treatment. [ Time Frame: ended 2011 ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Confirmed diagnosis of Cystic fibrosis
  • Chronic hypercapnia on room air in stable condition (PaCO2 between 45 and 55mmHg in two occasions separated by more than 4 weeks)
  • Informed consent

Exclusion Criteria:

  • Current treatment with non-invasive ventilation
  • PaCO2 more than 55 mmHg
  • Recent pneumothorax (within past 3 months)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00208078

Layout table for location information
Department of pulmonary disease of Cochin Hospital (AP-HP)
Paris, France, 75679
Sponsors and Collaborators
Cochin Hospital
Layout table for investigator information
Principal Investigator: Pierre-Régis Burgel Department of pulmonary disease of Cochin Hospital (AP-HP)
Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: Dr Pierre-Régis Burgel, Professor, Cochin Hospital Identifier: NCT00208078    
Other Study ID Numbers: 2206/08-11-04
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: February 13, 2013
Last Verified: February 2013
Keywords provided by Dr Pierre-Régis Burgel, Cochin Hospital:
Non-Invasive Ventilation
Additional relevant MeSH terms:
Layout table for MeSH terms
Cystic Fibrosis
Respiratory Insufficiency
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Respiration Disorders